Last update:
Oncology & Cancer news
Oncology & Cancer
Study uncovers mutations and DNA structures driving bladder cancer
How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...
1 hour ago
0
0
Oncology & Cancer
Investigators share four research-backed ways to reduce cancer risk
Some of the biggest steps people can take to reduce the risk of cancer include wearing sunscreen, quitting smoking, eating a healthy diet or limiting exposure to hazardous chemicals, just to name a few.
1 hour ago
0
0
New insights into glioblastoma treatment for elderly patients
A study led by Dr. Monika E. Hegi, MD, Ph.D. and European Organization for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, Dr. Thierry Gorlia, Ph.D.) reveals that elderly glioblastoma patients ...
1 hour ago
0
0
Scientists develop new precision tool to better predict outcomes for patients with liver cancer
Duke-NUS alumnus Dr. Marjorie Hoang and her mentor, Professor Pierce Chow, have brought clarity to the complex decision-making process patients diagnosed with intermediate-stage liver cancer and their doctors face by creating ...
1 hour ago
0
0
New study finds kinder, more targeted approach to treating aggressive childhood brain cancer
Researchers have identified a critical group of medulloblastoma, a form of brain cancer in children, which is near incurable using current therapies.
1 hour ago
0
0
Combination therapeutic strategy identified for triple negative breast cancer
Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women's Hospital are pointing the way toward therapeutic strategies ...
3 hours ago
0
0
Cancer survivors who smoke cigarettes more likely to use cannabis before, during and after treatment
Up to 40% of cancer patients use cannabis to help with treatment side effects like nausea, loss of appetite or pain.
2 hours ago
0
0
Heavy smokers can benefit from lung cancer screening using low-dose CT
Lung cancer screening using low-dose computed tomography (CT) offers more benefits than harms for heavy active and former smokers: The procedure can prevent some people from dying from lung cancer and may also prolong overall ...
1 hour ago
0
0
A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer: Now, it waits for patients
Within the next couple of weeks, the first blood samples from patients will arrive at the loading dock of Adaptimmune, a biotechnology company headquartered on the northeastern edge of the Navy Yard.
2 hours ago
0
0
Weight-loss surgery may lower risk of pancreatic cancer in people with obesity
Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate. A new analysis in Diabetes/Metabolism Research and Reviews suggests that weight-loss surgery—also ...
11 hours ago
0
1
DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the U.S. alone. They experience worse outcomes ...
22 hours ago
0
2
New technique that makes competition between tumor cells visible can help personalize treatments for multiple myeloma
Not all cells within the same cancer are the same. They all have genetic errors that turn them into tumor cells, but these errors are not identical. In each cancer, there are populations of cells with different mutations, ...
23 hours ago
0
82
Significant worldwide disparities seen in availability and timeliness of new cancer drugs
Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, with poorer countries missing out, ...
19 hours ago
0
27
AI could help identify women at risk for future breast cancer
Artificial intelligence (AI) scores may be able to estimate the risk for future breast cancer and lead to earlier diagnosis, according to a study published online Oct. 3 in JAMA Network Open.
21 hours ago
0
1
Prostate cancer Q&A: Improving detection and reducing overtreatment
Prostate cancer is the most common cancer among men in Sweden, with about 10,000 new cases diagnosed annually. Despite advancements in diagnostics and treatments, managing prostate cancer remains challenging due to its often ...
23 hours ago
0
7
Failure in a CAR T cell trial could unlock multiple treatments for acute myeloid leukemia
In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given patients and doctors an unprecedented weapon. CAR T cell therapy has demonstrated efficacy in treating ...
Cell line models identify cause of melanoma with drug resistance
Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known as the most lethal form of skin cancer due to its high rates of metastasis and recurrence. With ...
Oct 8, 2024
0
4
Mouse model suggests bacterial-derived metabolites may promote prostate cancer
Every year, over 1.5 million new cases of prostate cancer are diagnosed throughout the world. As one of the leading causes of death for men in multiple countries, understanding the risk factors for prostate cancer has become ...
Oct 8, 2024
0
52
Researchers reveal rare neurological symptoms in youth following CAR-T therapy
Researchers at Children's Hospital of Philadelphia (CHOP) revealed for the first time that children, adolescents and young adults may experience very rare neurological issues of paraparesis and quadriparesis following chimeric ...
Oct 8, 2024
0
0
Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors
In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.
Oct 7, 2024
0
73
Scientists discover that special immune cells stop metastatic cancer
Metastatic disease—when cancer spreads from the primary tumor to other parts of the body—is the cause of most cancer deaths. While researchers understand how cancer cells escape the primary site to seed new tumors, it's ...
Oct 7, 2024
0
36
AI model shows potential for identifying sex-specific risks associated with brain tumors
For years, cancer researchers have noticed that more men than women get a lethal form of brain cancer called glioblastoma. They've also found that these tumors are often more aggressive in men. But pinpointing the characteristics ...
Oct 7, 2024
0
22
Epigenetic test could help predict efficacy of immunotherapy in multiple myeloma
Multiple myeloma is a type of blood cancer that appears mainly after the age of 60. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the porous structure within the ...
Oct 7, 2024
0
1
Early blood test can predict survival in men newly diagnosed with metastatic prostate cancer, clinical trial finds
A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which patients should receive ...
Oct 7, 2024
0
18
Cancer biologists discover the drug, 5-fluorouracil, acts differently in different types of cancer
Since the 1950s, a chemotherapy drug known as 5-fluorouracil has been used to treat many types of cancer, including blood cancers and cancers of the digestive tract.
Oct 7, 2024
0
42
